| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |